Treatment Selection and Emerging Therapeutic Options in JAK-Inhibitor Refractory/ Intolerant Myelofibrosis_Srdan Verstovsek, MD, PhD
16:54
Myeloproliferative Neoplasm
Treatment Selection and Emerging Therapeutic Options in JAK-Inhibitor Refractory/ Intolerant Myelofibrosis_Srdan Verstovsek, MD, PhD
Myeloproliferative Neoplasm Similar Videos
Similar Videos
-
New treatments for MPNs, CML, and systemic mastocytosis_Ellen Ritchie, MD; #BeyondTheCongress
17:44
-
Therapeutic Options for Patients with JAK-Inhibitor–Naïve Myelofibrosis_Naveen Pemmaraju, MD
21:38
-
Later Phase Trials for MPNs, CML and Systemic Mastocytosis_Mark Heaney, MD, PhD; #hemeupdates2022
16:20
